Cargando…

Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide

Numerical and functional defects of invariant natural killer T cells (iNKT) have been documented in human and mouse cancers, resulting in a defect in IFN production in several malignancies. iNKT cells recognize glycolipids presented on CD1d molecules by dendritic and related cells, leading to their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowak, Michael, Arredouani, Mohammed S., Tun-Kyi, Adrian, Schmidt-Wolf, Ingo, Sanda, Martin G., Balk, Steven P., Exley, Mark A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892484/ https://www.ncbi.nlm.nih.gov/pubmed/20593019 http://dx.doi.org/10.1371/journal.pone.0011311

Ejemplares similares

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014)

The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells
por: Kitamura, Hidemitsu, et al.
Publicado: (1999)

Expansion of Lung Vα14 NKT Cells by Administration of α‐Galactosylceramide‐pulsed Dendritic Cells
por: Akutsu, Yasunori, et al.
Publicado: (2002)

In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma
por: Kikuchi, A, et al.
Publicado: (2001)

α‐Galactosylceramide‐activated murine NK1.1(+) invariant‐NKT cells in the myometrium induce miscarriages in mice
por: Ichikawa, Tomoko, et al.
Publicado: (2016)

NKT Cell Stimulation with α-Galactosylceramide Results in a Block of Th17 Differentiation after Intranasal Immunization in Mice
por: Zygmunt, Beata M., et al.
Publicado: (2012)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

α-Galactosylceramide Analogs with Weak Agonist Activity for Human iNKT Cells Define New Candidate Anti-Inflammatory Agents
por: Bricard, Gabriel, et al.
Publicado: (2010)

Activation of Invariant NKT Cells with Glycolipid Ligand α-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis
por: Horikoshi, Masanobu, et al.
Publicado: (2012)

Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy
por: Singh, M, et al.
Publicado: (2014)

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
por: Davitt, Christopher J. H., et al.
Publicado: (2019)

Vamps & tramps /
por: Paglia, Camille, 1947-
Publicado: (2001)

The Tramp Journal
Publicado: (1892)

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
por: Croudace, Joanne E, et al.
Publicado: (2008)

Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
por: Uchida, Takahiro, et al.
Publicado: (2018)

Paucity of CD4(+) Natural Killer T (NKT) Lymphocytes in Sooty Mangabeys Is Associated with Lack of NKT Cell Depletion after SIV Infection
por: Rout, Namita, et al.
Publicado: (2010)

Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15
por: Hsu, Chien-Ya, et al.
Publicado: (2021)

Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
por: Astigiano, Simonetta, et al.
Publicado: (2017)

Genistein chemoprevention of prostate cancer in TRAMP mice
por: Wang, Jun, et al.
Publicado: (2007)

Substrate specificity of the TRAMP nuclear surveillance complexes
por: Delan-Forino, Clémentine, et al.
Publicado: (2020)

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
por: Nowak, Michael, et al.
Publicado: (2011)

Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes
por: Ando, Tatsuya, et al.
Publicado: (2013)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

NKT Cell-TCR Expression Activates Conventional T Cells in Vivo, but Is Largely Dispensable for Mature NKT Cell Biology
por: Vahl, J. Christoph, et al.
Publicado: (2013)

CLEC4F Is an Inducible C-Type Lectin in F4/80-Positive Cells and Is Involved in Alpha-Galactosylceramide Presentation in Liver
por: Yang, Chih-Ya, et al.
Publicado: (2013)

Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model
por: Ito, Hiroyasu, et al.
Publicado: (2015)

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
por: Sartorius, Rossella, et al.
Publicado: (2018)

α‐galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice
por: Chen, Qianhui, et al.
Publicado: (2018)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule
por: Owczarek, Tomasz B., et al.
Publicado: (2013)

MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)
por: Arbab, Ali S, et al.
Publicado: (2011)

Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity
por: Bonorden, Melissa J. L., et al.
Publicado: (2012)

Quercetin–Resveratrol Combination for Prostate Cancer Management in TRAMP Mice
por: Singh, Chandra K., et al.
Publicado: (2020)

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
por: Dasyam, Nathaniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eha51k6dajns0na52shaf2oqks